Main Street Research LLC grew its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 397,082 shares of the company's stock after purchasing an additional 11,269 shares during the period. Procter & Gamble makes up about 4.4% of Main Street Research LLC's portfolio, making the stock its 3rd biggest position. Main Street Research LLC's holdings in Procter & Gamble were worth $67,671,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new stake in shares of Procter & Gamble during the fourth quarter valued at $5,244,463,000. GAMMA Investing LLC boosted its position in Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after buying an additional 7,913,335 shares during the period. Capital Research Global Investors grew its stake in Procter & Gamble by 62.5% in the 4th quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock worth $1,240,294,000 after acquiring an additional 2,846,560 shares in the last quarter. Northern Trust Corp grew its stake in Procter & Gamble by 10.1% in the 4th quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock worth $4,928,107,000 after acquiring an additional 2,703,757 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Procter & Gamble by 15.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after acquiring an additional 2,224,912 shares during the period. Hedge funds and other institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Performance
Procter & Gamble stock traded down $0.53 during mid-day trading on Wednesday, reaching $157.36. 18,769,238 shares of the company traded hands, compared to its average volume of 7,578,583. The firm's fifty day moving average is $161.98 and its two-hundred day moving average is $165.15. The company has a market capitalization of $368.94 billion, a price-to-earnings ratio of 24.98, a price-to-earnings-growth ratio of 4.49 and a beta of 0.40. Procter & Gamble Company has a fifty-two week low of $155.98 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.71 and a quick ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The firm had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. During the same period in the prior year, the firm earned $1.52 EPS. The firm's revenue was down 2.1% on a year-over-year basis. On average, equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.69%. The ex-dividend date of this dividend is Friday, July 18th. Procter & Gamble's payout ratio is 67.14%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on the company. Truist Financial decreased their target price on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Piper Sandler upped their price objective on shares of Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a research note on Monday, May 5th. Redburn Atlantic cut shares of Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 target price on the stock. in a report on Thursday, May 1st. Evercore ISI restated an "outperform" rating and issued a $190.00 price target (up previously from $170.00) on shares of Procter & Gamble in a report on Tuesday, June 3rd. Finally, Bank of America dropped their price objective on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $178.45.
Get Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In related news, CEO Jennifer L. Davis sold 1,000 shares of the firm's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the transaction, the chief executive officer owned 51,965 shares of the company's stock, valued at $8,386,111.70. This trade represents a 1.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the transaction, the insider owned 25,182 shares of the company's stock, valued at $3,995,627.94. The trade was a 29.47% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report